A9599 Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified

Short descriptor: Radioph dx b amyloid pet nos

⚠ Terminated HCPCS Level II 2026
Terminated Code
A9599 was terminated as of 2017-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open A9599 in the app →

Look up A9599 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

A9599 is the HCPCS Level II code for Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified (2026). It belongs to Section A — Transportation, Medical & Surgical Supplies. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Other carrier priced.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Other carrier priced (indicator 57)
Type of Service
Diagnostic radiology
Effective Date
2018-01-01
Termination Date
2017-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference A9599 with the canonical source and edition:

A9599 — Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/A9599

Canonical URL: https://icd10codingpro.com/hcpcs-codes/A9599

Related Codes in Section A

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial